Table 2 Treatment data of initial patients presenting to diabetes clinics at AKU
Variables | Overall | <18 years old | 18-35years old | 36-54years old | ≥55 years old | P-value |
|---|---|---|---|---|---|---|
n = 876 | n = 3 | n = 61 | n = 396 | n = 416 | ||
Treatment, n (%) | <0.002 | |||||
Insulin alone | 94(10.8) | 2(66.7) | 5(8.3) | 32(8.1) | 55(13.3) | |
OHA alone | 520(59.5) | 1(33.3) | 33(55.0) | 260(65.7) | 226(54.5) | |
Combine OHA and Insulin | 194(22.2) | 0(0) | 15(25.0) | 73(18.4) | 106(25.5) | |
Neither OHA nor Insulin | 66(7.6) | 0(0) | 7(11.7) | 31(7.8) | 28(6.7) | |
Lipid lowering agents (statins, fibrates, ezitimibe), n (%) | ||||||
Yes | 351(40.1) | 0(0) | 7(11.5) | 141(35.6) | 203(48.8) | <0.001 |
No | 525(59.9) | 3(100) | 54(88.5) | 255(64.4) | 213(51.2) | |
Antihypertensive Agents, n (%) | <0.001 | |||||
Yes | 461(52.6) | 1(33.3) | 15(24.6) | 175(44.2) | 270(64.9) | |
No | 415(47.4) | 2(66.7) | 46(75.4) | 221(55.8) | 146(35.1) | |
Antiplatelet, n (%) | <0.001 | |||||
Yes | 342(39.1) | 0(0) | 8(13.3) | 108(27.3) | 226(54.3) | |
No | 532(60.9) | 3(100) | 52(86.7) | 287(72.7) | 190(45.7) | |
Pregablin/ gabapentin, n (%) | 0.19 | |||||
Yes | 61(7.0) | 0(0) | 3(5.0) | 21(5.3) | 37(8.9) | |
No | 812(93.0) | 3(100) | 57(95.0) | 374(94.7) | 378(91.1) | |